Tag: BREEZE-AD7

JAK inhibition plus TCS lead to high clearance rates in AD

Presented By
Prof. Kristian Reich, Georg-August-University Göttingen, Germany
Trial
Phase 3, BREEZE-AD7
Type
Peer-reviewed article

9 December 2019 16:53
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com